Barclays downgraded shares of Taylor Wimpey (OTCMKTS:TWODY - Free Report) from a hold rating to a strong sell rating in a research report released on Wednesday,Zacks.com reports.
A number of other equities research analysts have also recently commented on the company. Kepler Capital Markets upgraded Taylor Wimpey to a "strong-buy" rating in a research note on Wednesday, July 23rd. Royal Bank Of Canada cut Taylor Wimpey from a "moderate buy" rating to a "hold" rating in a research report on Wednesday, July 9th.
Read Our Latest Stock Analysis on TWODY
Taylor Wimpey Trading Down 0.8%
Taylor Wimpey stock traded down $0.11 during mid-day trading on Wednesday, hitting $13.42. 50,378 shares of the company traded hands, compared to its average volume of 154,024. The stock has a fifty day moving average price of $15.42 and a 200-day moving average price of $15.10. Taylor Wimpey has a one year low of $13.05 and a one year high of $23.56.
Taylor Wimpey Company Profile
(
Get Free Report)
Taylor Wimpey plc operates as a homebuilder in the United Kingdom and Spain. It builds and delivers various homes and communities. Taylor Wimpey plc was incorporated in 1935 and is based in High Wycombe, the United Kingdom.
Featured Stories
Before you consider Taylor Wimpey, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Taylor Wimpey wasn't on the list.
While Taylor Wimpey currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.